Literature DB >> 29846772

Alkaline Phosphatase Activity of Staphylococcus aureus Grown in Biofilm and Suspension Cultures.

Kevin M Danikowski1, Tong Cheng2.   

Abstract

Staphylococcus aureus is known for its resistance to antibiotic treatment as well as the ability to form biofilms. Biofilm formation has been seen in S. aureus infections, yet, the mechanism of biofilm formation is not completely understood. Many molecules, such as DNA and polysaccharides, have been identified in the biofilm microenvironment, but little is known about the enzymes involved in the process. In this paper, alkaline phosphatase (ALP) activity was investigated in S. aureus grown either in biofilm or suspension cultures, achieved using DNase I. A significant increase of ALP activity was observed in S. aureus biofilm culture compared to its suspension counterpart. Treatment of sodium orthovanadate, an ALP inhibitor, significantly decreased biofilm formation. Its inhibition was on par with DNase I treatment at specific doses. Thus, ALP may play an important role in the biofilm formation. Likewise, ALP inhibition may be a novel target for anti-biofilm therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29846772     DOI: 10.1007/s00284-018-1514-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  28 in total

1.  Cloning of the gene and characterization of the enzymatic properties of the monomeric alkaline phosphatase (PhoX) from Pasteurella multocida strain X-73.

Authors:  Jin-Ru Wu; Jui-Hung Shien; Happy K Shieh; Chung-Chi Hu; Shuen-Rong Gong; Ling-Yun Chen; Poa-Chun Chang
Journal:  FEMS Microbiol Lett       Date:  2006-11-29       Impact factor: 2.742

Review 2.  The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data.

Authors:  M Malone; T Bjarnsholt; A J McBain; G A James; P Stoodley; D Leaper; M Tachi; G Schultz; T Swanson; R D Wolcott
Journal:  J Wound Care       Date:  2017-01-02       Impact factor: 2.072

Review 3.  Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Authors:  Jason Fawley; David M Gourlay
Journal:  J Surg Res       Date:  2015-12-17       Impact factor: 2.192

4.  Phosphorylation controls the functioning of Staphylococcus aureus isocitrate dehydrogenase--favours biofilm formation.

Authors:  U Venkateswara Prasad; D Vasu; S Yeswanth; V Swarupa; M M Sunitha; A Choudhary; P V G K Sarma
Journal:  J Enzyme Inhib Med Chem       Date:  2015-03-06       Impact factor: 5.051

5.  Evaluation of different detection methods of biofilm formation in the clinical isolates.

Authors:  Afreenish Hassan; Javaid Usman; Fatima Kaleem; Maria Omair; Ali Khalid; Muhammad Iqbal
Journal:  Braz J Infect Dis       Date:  2011 Jul-Aug       Impact factor: 1.949

6.  Cell wall teichoic acid as a reserve phosphate source in Bacillus subtilis.

Authors:  W D Grant
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

7.  Inhibition of human alkaline phosphatases by vanadate.

Authors:  L E Seargeant; R A Stinson
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

Review 8.  Structure and mechanism of alkaline phosphatase.

Authors:  J E Coleman
Journal:  Annu Rev Biophys Biomol Struct       Date:  1992

9.  The economic impact of Staphylococcus aureus infection in New York City hospitals.

Authors:  R J Rubin; C A Harrington; A Poon; K Dietrich; J A Greene; A Moiduddin
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

10.  Staphylococcus aureus glucose-induced biofilm accessory proteins, GbaAB, influence biofilm formation in a PIA-dependent manner.

Authors:  Yibo You; Ting Xue; Linyan Cao; Liping Zhao; Haipeng Sun; Baolin Sun
Journal:  Int J Med Microbiol       Date:  2014-04-26       Impact factor: 3.473

View more
  1 in total

1.  In vitro and in silico evaluation of the inhibitory effect of a curcumin-based oxovanadium (IV) complex on alkaline phosphatase activity and bacterial biofilm formation.

Authors:  G Katsipis; V Tsalouxidou; E Halevas; E Geromichalou; G Geromichalos; A A Pantazaki
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.